Saroja Pharma Indus IND L

NSE: SAROJA · Other · sector

₹40.80NSE close 2026-10-19

Key numbers

Market cap₹16 cr

Price₹40.80

52w high / low₹44 / ₹28

P/E10.2xSector median 14.4x

P/B1.2xSector median 1.7x

Book value₹33.0

Dividend yield–Sector median 0.37%

ROE13.0%Sector median 13.8%

ROCE27.9%Sector median 19.6%

OPM5.3%Sector median 10.4%

Debt / equity–Sector median 0.29x

EV/EBITDA4.3xSector median 8.4x

Interest cover2.5x

Current ratio1.09x

Sales growth 3y–Sector median +7.7%

Profit growth 3y–Sector median +16.6%

PEG–

Last 12 months to Mar 2026, Standalone. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Operating profit covered interest 2.5x in the last 12 months.
Operating cash flow was below net profit in 0 of the last 3 years.
Other income was 7% of net profit in the last 12 months.
No dividend in the last 3 financial years.
Price ₹40.80 on 2026-10-19: -6.5% from the 52-week high, +45.7% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹59.25 · low ₹28.15

Quarterly results

₹ cr	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Revenue	21	20	19	35	38	32
EBITDA	1	1	1	2	1	3
OPM %	5.5%	7.1%	6.0%	4.7%	2.5%	8.6%
Other income	0	-0	0	0	0	-0
Net profit	0	0	0	1	1	1
EPS (₹)	1.68	0.00	0.00	1.74	1.42	2.60
Revenue YoY					+81.6%	+62.5%
Profit YoY					+14.0%	+173.7%

Standalone figures where filed. Latest quarter Mar 2026.

Profit & loss (yearly)

₹ cr	FY24	FY25	FY26	TTM
Revenue	41	54	70	70
EBITDA	3	3	4	4
Net profit	1	1	2	2
EPS (₹)	0.00	2.57	4.02	4.02
Revenue growth		+32.1%	+30.5%	–
Profit growth		+17.0%	+57.3%	–
Dividend / share (₹)	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	–	–	–
Net profit	–	–	–
EPS	–	–	–
Share price	–	-14.6% (2y)	-8.3%

Balance sheet

₹ cr	FY24	FY25	FY26
Shareholders' equity	–	12	13
Cash & equivalents	–	0	0
Total assets	–	40	42
Fixed assets	–	3	2
Investments	–	0	1
Inventory	–	0	1

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY24	FY25	FY26
Cash from operations	2	22	7
Cash from investing	-5	-3	-12
Cash from financing	7	2	4
Capex	0	0	12
Free cash flow	2	22	-4

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY24	FY25	FY26
ROE %	–	8.9%	12.2%
ROCE %	–	24.5%	27.9%
Inventory days	–	1	5
Working capital days	–	32	8

Peers in Other

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
TSFINV	₹8,585 cr	17.6x	1.4x	8.4%	3.6%	20.5%	+121.7%	2.30%
KRISHANA	₹6,339 cr	39.9x	11.3x	41.6%	23.2%	12.6%	+95.7%	0.05%
MARINE	₹5,431 cr	84.2x	11.0x	14.3%	18.0%	10.8%	+25.6%	0.07%
ZOTA	₹4,139 cr	–	6.0x	-22.5%	-12.4%	-0.5%	+56.7%	0.07%
AIMTRON	₹3,319 cr	71.7x	17.1x	28.0%	31.8%	21.8%	–	–
ACCORD	₹2,984 cr	–	261.7x	12.4%	12.0%	2.4%	–	–
MONOLITH	₹2,646 cr	64.6x	24.3x	36.0%	48.7%	24.4%	–	–
UTSSAV	₹2,390 cr	40.2x	14.1x	43.4%	54.7%	7.9%	–	–
BETA	₹2,200 cr	40.6x	5.0x	16.4%	17.0%	20.8%	–	–
SAROJA	₹16 cr	10.2x	1.2x	13.0%	27.9%	5.3%	–	–

All 688 companies in Other →

Documents

Links go to the original files on the exchange website.

About the company


Sector
Industry	Other
Sub-industry
Symbol	SAROJA
BSE code	–
ISIN	INE0PCL01011
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-24 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-19.